BioSpace News Archive

Combining the strengths of MAIN5 and Iperion Life Sciences Consultancy for the benefit of the European Pharmaceutical Industry.

Successful validation of standardized clinical procedure for instillation of nanoparticles in first patient cohort

Colorado teenager Olivia Goodreau has garnered support from some of the world’s top scientists as a leading advocate for Lyme disease awareness and research funding.

On Tuesday, the U.K. pharma giant optioned to license an antisense treatment from Ionis Pharmaceuticals following positive Phase II results in chronic hepatitis B virus infection.

This study aimed to determine the appropriate dose for Japanese patients treated with lurbinectedin, in monotherapy, for advanced solid tumors.

Oncoceutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Investigational New Drug (IND) application for ONC206, allowing the first-in-human trial of the compound. ONC206 is the first of the family of drug candidates, which we call “imipridones”, that possess the same core chemical structure as ONC201.

Today the Society for Clinical Research Sites (SCRS) announced the top 5 sponsor and CRO finalists for the 2019 SCRS Eagle Award™, selected from companies nominated by SCRS members.

Breztri Aerosphere is a triple combination drug of budesonide, glycopyrronium and formoterol fumarate.

Researchers at Washington University School of Medicine in St. Louis and biotech startup VaxNewMo have developed an experimental vaccine against K. pneumoniae that is effective in mice.

Companies from across the globe provide updates on their business and pipelines.